Pharmacoeconomics: Growth in Cancer Diagnostics Means Market Opportunity

Autor:	Paul Crowe
Rok vydání:	2017
Předmět:	Economics and Econometrics medicine.medical_specialty Precision medicine Profit (economics) Cost savings Food and drug administration Clinical trial Pharmacoeconomics Market analysis medicine Medical physics Business health care economics and organizations Finance Moderate growth
Zdroj:	The Journal of Private Equity. 21:48-50
ISSN:	2168-8508 1096-5572
Popis:	Testing for precision diagnostics in cancer is underway in Food and Drug Administration clinical trials. This new technology will outdate current, inaccurate technologies (i.e., mammograms and prostate-specific antigen tests) and become part of routine health screenings. Cost savings translate to bigger profit potential for hospitals and laboratories that conduct the tests. Trends in precision medicine will turn the diagnostics sector from its current moderate value/moderate growth status to one replicating the explosive growth of biotech.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::db62f88032545e88891d9628614a23a5 https://doi.org/10.3905/jpe.2017.21.1.048 Zobrazit plný text záznamu